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Abstract
In order to isolate new G protein-coupled receptors expressed in the cerebral cortex, a set of degenerate oligonucleotides
corresponding to the third and seventh transmembrane segment were synthetized. Their use in PCR on rat brain cortex
mRNA amplified several cDNA fragments. One of them, a 526 bp sequence, encoded for what was at that time an unknown
G protein-coupled receptor. An oligonucleotide derived from the sequence was then used as a probe to isolate the receptor
cDNA from a rat brain cDNA library. It encodes for a 353aa protein with seven transmembrane segments, three consensus
N-glycosylation sites at the amino terminus and several potential phosphorylation sites in the intracellular loops. This
protein shares 91% overall identity with a recently cloned human somatostatin-like receptor of 402aa named SLC-1. This
suggests that we have cloned the rat orthologue of the human SLC-1. However, the extracellular N-terminus of the human
receptor is 49 amino acids longer and shows 50% identity with the rat one. Because the human sequence was deduced from
genomic DNA, we suspected the presence of an intron in the gene. This was confirmed by PCR using primers spanning the
intron. On the basis of the sequence of a 128 kb fragment of chromosome 22 encompassing the SLC-1 gene, we were able
to deduce a corrected amino acids sequence for the human receptor. So both rat and human SLC-1 receptors are 353aa long,
with three consensus N-glycosylation sites. They share 96% identity at the amino acid level and are encoded by a gene
containing one intron in the coding sequence. q 1998 Elsevier Science B.V.
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In a living organism, the cells communicate with
each other through extracellular signals. These are
transmitted into the cell by various classes of mem-
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polymerase chain reaction; TM, transmembrane segment; aa,
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brane receptors. In the central nervous system, infor-
mation flows from one neuron to another using three
classes of receptors: the ligand-gated ion channels
w x w x1,2 , the tyrosine kinase receptors 3,4 and the G
w xprotein-coupled receptors 5,6 . This last class of
receptors is known to recognize a wide variety of
substances including proteins, peptides hormones, nu-
cleotides, amino acids neuromodulators, neurotrans-
mitters, lipids autocoids, sugar and alkaloids, as well
as volatile organic odorants, calcium ions and even
w xphotons 7 . GPCRs have been identified in organ-
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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isms as evolutionarily divergent as yeast and man and
all share a similar topological organisation i.e. one
polypeptide chain with seven transmembrane seg-
w xments 8,9 . Up to now, more than 250 receptors of
this superfamily have been cloned and sequenced.
However, it is thought that there exist up to a thou-
sand GPCRs. Isolating new GPCRs could therefore
refine our understanding of cell to cell communica-
tion in the brain. For this purpose, we have used a
w xPCR approach with degenerate primers 10 . The
amino acid sequences of 26 receptors belonging to
the adrenergic, dopaminergic, muscarinic and sero-
tonergic families were aligned. Three boxes of 9
residues showing more than 30% identity were found
Fig. 1. Nucleotide and deduced amino acid sequences of the rat cDNA clone C12. Noncoding sequence is shown in lowercase. The
putative TM are underlined. Circles indicate potential asparagine-linked glycosylation site. Diamonds, triangles and asterisk indicate
amino acids that are consensus phosphorylation sites for protein kinase C, A and protein kinase CK2 respectively.
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in TM III, VI and VII. Two 232 fold degenerate
oligonucleotides were derived from the sequences of
 .qTM III and VII. Poly A RNA isolated from rat
 .cerebral cortex Qiagen Oligotex kit was first re-
 .verse transcribed using M-MLV Gibco BRL and
 .oligo dT and then submitted to PCR. Forty cycles of
1 min at 938C, 2 min at 508C and 2 min at 728C were
followed by a 10 min extension at 728C. Several
cDNA fragments of various size were amplified,
 .  .subcloned in pGEM11Zf q Promega and se-
quenced by the Sanger dideoxynucleotide chain ter-
mination method. One of them, a 526 bp cDNA
fragment, encoded part of a new receptor which at
that time displayed only 30 to 35% identity with the
partial sequences of the five somatostatin receptors
w x11–15 . An oligonucleotide probe derived from this
cDNA sequence was used to screen 5=105 plaques
 .from a rat brain cDNA library Clontech . One of
them, referred to as C12, that strongly hybridized to
the probe at high stringency condition was purified.
Sequencing of the cDNA insert revealed a 1059 bp
open reading frame encoding a putative protein of
353 residues with a calculated molecular mass of
 .39 017 Da Fig. 1 . Hydropathy analysis indicates that
the secondary structure of this protein contains 7 TM
common to GPCRs. Other features in common with
 .many GPCRs include the following: 1 in the extra-
cellular N-terminus three consensus sites for as-
 .paragine-linked glycosylation Asn–Xaa–SerrThr ;
 .2 in the intracellular loops two potential phosphory-
lations sites for protein kinase A ArgrLys–
.ArgrLys–Xaa–SerrThr , six for protein kinase C
 .SerrThr–Xaa–ArgrLys and one for protein kinase
 . w xCK2 SerrThr–Xaa–Xaa–AsprGlu 16 . The amino
acid sequence exhibits 91% overall identity to a
newly cloned human somatostatin-like receptor named
w xSLC-1 17 , 30 to 35% identity to the rat somatostatin
receptors and less than 30% identity with other
GPCRs. This suggest that C12 is the rat orthologue of
SLC-1. However there are several differences be-
Fig. 2. Comparison of the amino acids sequences of the rat C12 receptor with the human SLC-1 receptor published by Kolakowski et al.
w x17 .
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 .tween them Fig. 2 . The SLC-1 protein is 402aa long
and the 49 ‘‘extra’’ amino acids are all located at the
extracellular N-terminus. Moreover, the non con-
served amino acids are not randomly distributed along
the 353aa the receptors have ‘‘in common’’. Over the
first 25 residues i.e. 2 to 26 for C12 and 50 to 75 for
.SLC-1 , there are 22 different ones but over the last
327 residues i.e. 27 to 353 for C12 and 76 to 402 for
.SLC-1 there are only seven differences. Such type of
differences have never been observed when compar-
ing rat and human GPCR orthologues. First, we have
searched for sequencing errors. Analysis of the vari-
ous open reading frames in the two sequences reveal
that frame shift errors could be rejected. As the
SLC-1 sequence was obtained from genomic DNA
but the C12 one was deduced from cDNA, we sus-
pected the presence of an intron in the gene. This
assumption was strengthened by the presence, in the
SLC-1 nucleotide sequence, of a consensus splice
acceptor site just at the beginning of the conserved
 76 77region coding for Pro –Gly in the SLC-1 se-
.quence . To confirm this hypothesis, two oligo-
nucleotides derived from residues Ala14–Gln21 and
Gly 57–Ile62 of the C12 sequence were used in a PCR
experiment. As shown in Fig. 3, the amplification
fragment obtained from rat genomic DNA is larger
than the one obtained from the rat brain cDNA,
confirming the presence of an intron. A similar result
was obtained on human genomic DNA, also suggest-
ing the presence of an intron. These fragments were
 .subcloned in pCR2.1 Invitrogen and sequenced in
both direction. As shown in Table 1, the 5X and 3X
splice junction sequences found are in good agree-
ment with the consensus sequences described by
w xMount 18 . The rat intronic sequence is 46 nu-
cleotides longer than the human one and they share
Fig. 3. Display of an intron in the genes encoding for the C12
and SLC-1 receptors. PCR were performed with 0.3mg of ge-
 .  .qnomic DNA Clontech or 0.1mg of poly A RNA for 33
cycles. Annealing temperature was 588C.
Table 1
Exonrintron splice junctions for rat C12 and human SLC-1 gene
coding sequences
Uppercase letters represent exon sequence, lowercase letters rep-
resent intron sequence. Numbered amino acids refer to the cor-
rected SLC-1 sequence and the C12 sequence see text and Fig.
.4 .
67% identity at the nucleotide level. A dinucleotide
 .repeat of the form CA was found in the two intronsn
 .but is longer in the rat ns21 than in the human
 . w xn"10–13 17 . Our results were in agreement with
those obtained by Buck on a 128 kb fragment of the
human chromosome 22 encompassing the SLC-1 gene
 .accession number: Z86090 . On the basis of his
nucleotide sequence, we have deduced a corrected
amino acid sequence for the N-terminus of the SLC-1
 .receptor Fig. 4 . It is interesting to note that, on
Buck’s genomic sequence the open reading frame
continue to another methionine located 82 amino
acids upstream the one chosen. However we didn’t
take it into account because several trials of 5XRACE
 .Boehringer Mannheim performed on the rat brain
 .qpoly A RNA did not extent the sequence more
than twelve nucleotides upstream the cDNA sequence
presented in Fig. 1. Both introns were located at the
same place in the sequences of the two receptors i.e.
in the triplet coding for Gly 28. This location at the
N-terminus is quite unusual as they are found mainly
in the intra or extracellular loops and at the C-terminus
of GPCRs. The corrected SLC-1 receptor sequence
and the C12 one are 353aa long with three consensus
N-glycosylation sites. They show 96% identity and
are encoded by a gene possessing one intron in the
coding sequence.
Fig. 4. Comparison of the N-terminus of the C12 and the
corrected SLC-1 receptors. The arrow indicates the position of
the intron.
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